肿瘤学中靶向治疗的出现让伴随诊断检测的需求大大增加。新一代测序（NGS）是个理想的解决方案，可将一系列单基因检测的肿瘤图谱分析模式转化成多个分析物的方法，以带来精准的肿瘤学。
Illumina provides an innovative portfolio of NGS systems, products, and services for many phases of the drug development pipeline.
This DrugDev Consortium-designed genotyping array covers ADME genes and the druggable genome to support drug target selection and validation.